Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia
Status:
Withdrawn
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the clinical safety and tolerability of vabicaserin in Japanese
subjects that have a sudden worsening of their symptoms of schizophrenia. The study will also
assess the efficacy of vabicaserin and compare it to risperidone.